GastroCE
LECTURECME

Incorporating Patient-reported Outcomes (PROs) into the Management of Inflammatory Bowel Disease

Author(s)/Faculty: Peter D.R. Higgins, MD, PhD, MSc; Gil Y. Melmed, MD, MS; Megan E. Riehl, PsyD
Release Date: 7/17/2020Expiration Date: 7/16/2021
Credit Type: CMENumber of Credits: 1.25
Content Type: LectureProvider:
Inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn’s disease, affects an estimated 3 million adults in the United States and is increasing in incidence and prevalence. In the quest to optimize outcomes, clinicians providing care to patients with IBD face numerous challenges, including determining disease severity, treating the newly diagnosed patient, understanding and incorporating the use of available biologic agents and newer treatment options with novel mechanisms of action, and applying strategies for therapeutic drug monitoring. Therefore, continuing education is vital to help clinicians stay abreast of the latest evidence-based management approaches. The faculty of IBD Forum 2020 will review the current IBD guidelines, biologic agents, and combination therapies and will address other identified educational gaps.